omniture
药明生物 WuXi Biologics

Latest News

WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development

SHANGHAI, Dec. 13, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-12-13 07:30 643

WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity

SHANGHAI, Dec. 12, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-12-12 08:08 556

Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million

SHANGHAI and OXFORD, the United Kingdom, Dec. 11, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a ...

2018-12-11 15:00 517

Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million

SHANGHAI and OXFORD, the United Kingdom, Dec. 10, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a...

2018-12-11 09:47 498

WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics

SHANGHAI, Dec. 10, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-12-10 10:21 634

WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"

SHANGHAI and LONDON, Dec. 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-a...

2018-12-06 18:20 446

WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"

SHANGHAI and LONDON, Dec. 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-a...

2018-12-06 18:12 248

WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

SHANGHAI and DUNDALK, Ireland, Dec. 5, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading glo...

2018-12-05 23:29 646

WuXi Biologics Selected as Forbes Asia's Best Under A Billion 2018

SHANGHAI and TOKYO, Nov. 29, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-a...

2018-11-29 21:28 630

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

SHANGHAI and SEOUL, Nov. 28, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK, WuXi Bio), a leading glo...

2018-11-28 19:44 594

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai

SHANGHAI, Nov. 22, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-11-22 14:31 506

WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting

SHANGHAI, Nov. 7, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biolo...

2018-11-07 17:51 652

WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang

* The new Biologics Center will be one of the largest in northern China SHIJIAZHUANG, China, Oct. ...

2018-10-31 16:08 636

WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed

SHANGHAI, Oct. 29, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-10-29 20:10 647

CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics

BEIJING and SHANGHAI, Oct. 23, 2018 /PRNewswire/ -- CANbridge Pharmaceutical Inc., a biopharmaceuti...

2018-10-23 20:00 383

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs

SHANGHAI, Sept. 26, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-09-26 19:24 714

WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board

SHANGHAI, Sept. 24, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-09-25 08:00 444

WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board

SHANGHAI, Sept. 25, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-09-25 08:00 564

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 18, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-09-18 08:08 609

WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing

SHANGHAI, Sept. 11, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK, WuXi Bio), a leading global open-...

2018-09-11 08:38 647
12345